Datar Cancer Genetics (DCG) today announced the launch of Target-MRD, an advanced molecular residual disease (MRD) monitoring blood test for solid organ cancers. Target-MRD is a blood test based on ...
Body dissatisfaction can be minor, too bad my nose is so big, or it can be severe, I hate everything about my body.Once you start to think that you have a flaw, your mind runs with the distraction ...
Heterogeneity in prevalence estimates identified across studies and regions indicates that more research is required to draw stronger conclusions about the scale of OCSEA. However, the findings of ...